[1]Maniotis AJ, Folberg R, Hess A, et al.Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry[J].Am J Pathol, 1999, 155(3):739-752
[2]Paulis YM, Soetekouw PM, Verheul HM, et al.Signalling pathways in vascullogenic mimicry[J].Biochim Biophys Acta, 2010, 1806(1):18-28
[3]Qiao LL, Liang N, Zhang JD, et al.advanced research on vasculogenic mimicry in cancer[J].J Cell Mol Med, 2015, 19(2):315-326
[4]Spiliopoulos K, Peschos D, Batistatou A, et al.Vasculogenic mimicry: lessons from melanocytic tumors[J].In Vivo, 2015, 29(3):309-317
[5]Folberg R, Maniotis AJ.Vasculogenic mimicry[J].APMIS, 2004, 112(7-8):508-525
[6]Hao X, Sun B, Zhang S, et al.Microarray study of vasculogenic mimicry in bi-directional differentiation malignant tumor [J][J].Zhonghua Yi Xue Za Zhi, 2002, 82(19):1298-1302
[7]Baeten CI, Hillen F, Pauwels P, et al.Prognostic role of vasculogenic mimicry in colorectal cancer[J].Dis Colon Rectum, 2009, 52(12):2028-2035
[8]Li Y, Sun B, Zhao X, et al.Subpopulations of uPAR+ contribute to vasculogenic mimicry and metastasis in large cell lung cancer[J].Exp Mol Pathol, 2015, 98(2):136-144
[9]Sood AK, Seftor EA, Fletcher MS, et al.Molecular determinants of ovarian cancer plasticity[J].Am J Pathol, 2001, 158(4):1279-1288
[10]Tu DG, Yu Y, Lee CH, et al.Hinokitiol inhibits vasculogenic mimicry activity of breast cancer stemprogenitor cells through proteasome-mediated degradation of epidermal growth factor receptor[J].Oncol Lett, 2016, 11(4):2934-2940
[11]Shirakawa K, Wakasugi H, Heike Y, et al.Vasculogenic mimicry and pseudo-comedo formation in breast cancer[J].Int J Cancer, 2002, 99(6):821-828
[12]Mao JM, Liu J, Guo G, et al.Glioblastoma vasculogenic mimicry: signaling pathways progression and potential anti-angiogenesis targets[J].Biomark Res, 2015, 18(3):8-17
[13]Cai Xuansong, Jia Yongwei, Mei Jiong, et al.Tumor blood vessels formation in osteosarcoma: vasculogenesis mimicry[J].Chin J Med, 2004, 117(1):94-98
[14]Luo F, Yang K, Liu RL, et al.Formation of vasculogenic mimicry in bone metastasis of prostate cancer: correlation with cell apoptosis and senescence regulation pathways[J].Pathol Res Pract, 2014, 210(5):291-295
[15]Ahmadi SA, Moinfar M, Gohari Moghaddam K, et al.Practical application of angiogenesis and vasculogenic mimicry in prostatic adenocarcinoma[J].Arch Iran Med, 2010, 13(6):498-503
[16]Sharma N, Seftor RE, Seftor EA, et al.Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry[J].Prostate, 2002, 50(3):189-201
[17]范跃祖, 孙伟, 张文忠, 等.原发性胆囊癌患者肿瘤血管生成拟态及其临床意义[J].中华医学杂志, 2007, 87(3):145-149
[18]陈万青, 郑荣寿, 张思维.年中国恶性肿瘤发病和死亡分析[J].中国肿瘤, 2016, 25(1):1-8
[19] 汤钊猷.现代肿瘤学 [M]. 第二版. 上海:上海医科大学出版社,2000,775-818.
[20]施东华,王小林.大肠癌肝转移机制及诊治进展[J].中国医学计算机成像杂志, 2010, 16(1):81-86
[21]赵景松.不同部位大肠癌肝转移分布的临床研究[J].肿瘤, 2001, 21(1):61-62
[22]王俊,顾玉明.血管生成拟态在肝癌中的研究进展[J].当代医学, 2012, 18(6):112-115
[23]Cao Z, Bao M, Miele L, et al.Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis[J].Eur J Cancer, 2013, 49(18):3914-3923
[24]Liu R, Yang K, Meng C, et al.Vasculogenic mimicry is a marker of poor prognosis in prostate cancer[J].Cancer Biol Ther, 2012, 13(7):527-533
[25]Chen YS, Chen ZP.vasculogenic mimicry: a novel target for glioma therapy[J].Chin J Cancer, 2014, 33(2):74-79
[26]Fan YZ, Sun W.molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy[J].World J Gastrointest surg, 2010, 2(4):117-127
[27] Hendrix MJ, Seftor EA, Seftor RE, et al.Tumor cell vascular mimicry: Novel targeting opportunity in melanoma [J].[J].Pharmacol Ther, 2016, 159(3):83-92
|